Prostate MRI before biopsy is becoming standard practice at U.S. hospitals, with usage climbing sharply in recent years. The shift follows a body of evidence from multiple randomized trials demonstrating that imaging the prostate first and then targeting suspicious lesions improves detection of the aggressive cancers that matter most.
Guidelines have been updated to reflect this advance, and hospitals are responding by integrating MRI into their diagnostic workflows. The trend marks a real improvement in prostate cancer diagnosis, moving away from systematic sampling toward a more precise, image-guided approach.
While the source notes the increase is sharp, it does not provide specific numbers or compare adoption rates across hospital types. The overall direction is clear: pre-biopsy MRI is now a key tool in catching clinically significant disease earlier and more reliably.